Real-world data suggested similar effectiveness with tofacitinib or ustekinumab for ulcerative colitis patients with prior biologic failures. However, among those exposed to three or more advanced ...
Favorable outcomes were observed among patients with vitiligo who received systemic Janus kinase inhibitors, with tofacitinib associated with the highest rate of complete resolution. Tofacitinib may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results